Announcements Trials
Browse Landscape

Phase

Phase 2 31Phase 3 29Phase NA 14Phase 1 9Phase 2/3 3Phase 1/2 3

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 49INDUSTRY 16NIH 4NETWORK 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Lymphoma 4Colorectal Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia 2Xerostomia 1Warts 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Tongue Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Stomach Neoplasms 1Sezary Syndrome 1Seminoma 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Prostatic Neoplasms 1Previously Treated Non-Small Cell Lung Cancer 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Pain 1

Interventions

Oxaliplatin 2Capecitabine 2aflibercept 1Surgical Procedures, Operative 1Mitomycin 1Leucovorin 1Fluorouracil 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × NETWORK × Colorectal Neoplasms × Clear all
NCT01196260 2018-02-20

Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III

State Key Laboratory of Cancer Biology

Phase 2/3 Unknown
8,000 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01646554 2017-05-09

BOS3

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Withdrawn
Gastrointestinal

Colorectal Neoplasms

NCT00294359 2007-08-22

The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer

Australasian Gastro-Intestinal Trials Group

Phase 2/3 Completed
333 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡